BioNTech, FDA and Malaria

U.S. FDA places clinical hold on BioNTech's malaria vaccine study
 · 16hBioSpace
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
 · 1dFierceBiotech
BioNTech's RNA malaria vaccine trial hit by FDA hold
FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.
Trump Administration Cancels Meeting of FDA Vaccine Advisers, Risking Flu-Shot Delay
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season.
FDA meeting to choose flu vaccine composition canceled without explanation
A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for this fall’s flu season has been canceled, a member of the advisory committee told CNN.
Meeting of US FDA vaccine advisers canceled, committee member says
It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top health official earlier this month.
FDA cancels flu vaccine meeting and now health experts are worried
The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.
Doctor reacts to cancellation of FDA advisory committee meeting on flu vaccine
The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, raising concerns about the timeline for manufacturing next winter's flu shots.
STAT6d
FDA cancels vaccine advisory committee meeting
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in their shots for the next flu season.
FDA cancels meeting to choose flu strains for next year's vaccine
The Food and Drug Administration Wednesday abruptly and unexpectedly cancelled a planned March 13 vaccine advisory committee meeting that was to have chosen the flu strains in next year's U.S. flu vaccine.
FDA cancels meeting to choose flu vaccine strain
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.